Inactive

The action being approved is the ability to solicit for DLA requirements on an Other Than Full and Open Competition basis in accordance with FAR 6.302-1.The supplies to be acquired are various types o... The action being approved is the ability to solicit for DLA requirements on an Other Than Full and Open Competition basis in accordance with FAR 6.302-1.The supplies to be acquired are various types of Abbott Vascular cardiovascular products that fall into the following product categories: Atrial Fibrillation (AF), Coronary, Cardiac Rhythm Management (CRM), Endovascular, Heart Failure Management (HFM), Mechanical Circulatory Support (MCS), Neuromodulation Devices (NMD), and Structural Heart Devices (SHD).The proposed acquisition will result in a five-year Fixed Price Indefinite Delivery/Indefinite Quantity contract. Defense Logistics Agency (DLA) Troop Support, Medical Supplier Operations, is the contracting activity.

Inactive

The goal of the Manufacturer Direct Program is to establish an alternative to manual open market purchase activity and re-engineer the business process with an automated e-commerce business solution. ... The goal of the Manufacturer Direct Program is to establish an alternative to manual open market purchase activity and re-engineer the business process with an automated e-commerce business solution. The objective of this solicitation is to establish a Fixed Price (with Economic Price Adjustment) Indefinite Delivery/Indefinite Quantity (IDIQ) contract with Abbott Laboratories (Abbott) for their Cardiovascular "procedural packages". The "procedural package" includes the Abbott Vascular cardiovascular products that fall into the following product categories: Atrial Fibrillation (AF), Coronary, Cardiac Rhythm Management (CRM), Endovascular, Heart Failure Management (HFM), Mechanical Circulatory Support (MCS), Neuromodulation Devices (NMD), and Structural Heart Devices (SHD). These procedural packages include cardiovascular product lines, instrumentation sets, and ancillary accessories (such as needles for entry and guide wire) that are necessary for the physician to perform cardiovascular surgery. The product mix that makes up the "procedural package" varies based on the individual needs of the patient. Other sole-source Abbott product groups may be solicited at a future date under the forthcoming solicitation. The solicitation contains an on-site personnel requirement for the contractor to provide advice and guidance to physicians before, during, and after implantation of the device at the request of the Medical Treatment Facility. Technical support shall be available twenty-four (24) hours a day, seven (7) days a week. Market research has revealed that there are no other known manufacturers or distributors other than Abbott who can provide DoD hospitals with the complete "procedural package" under all three delivery methods and have direct control over a sales force that is knowledgeable in Abbott’s products. The Abbott Sales Representatives are experts on the vendor's products and are a vital part of helping to ensure that the patient is getting the necessary treatment. Abbott will have their product line loaded in the DLA Troop Support Medical Electronic Catalog (ECAT) system. All Orders, Order Confirmations, Invoices, and Payment transactions are required to be electronic. Items will be delivered to various Department of Defense (DoD) research centers, hospitals, clinics, and any federal customer participating in this program. The terms of the contract will be a one-year Base Ordering Period and four one-year unilateral Option Periods. The contract maximum is $117,140,796.00.over the five-year life of the contract. Solicitation SPE2DE-22-R-0015 is estimated to be issued late August 2022 and can be found on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. The point of contact is Kevin Buckman, DLA Troop Support- FSCB, kevin.buckman@dla.mil. The solicitation may not become available until the solicitation issue date.